Michael D Kappelman

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. doi request reprint Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population-based Cohort Study With 30 Years of Follow-up Evaluation
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Electronic address
    Clin Gastroenterol Hepatol 12:265-273.e1. 2014
  2. pmc Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, 200 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Dig Dis Sci 58:519-25. 2013
  3. pmc Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
    Michael D Kappelman
    University of North Carolina Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 17:62-8. 2011
  4. doi request reprint Quality of care for gastrointestinal conditions: a primer for gastroenterologists
    Michael D Kappelman
    Division of Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 106:1182-7. 2011
  5. doi request reprint Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
    Michael D Kappelman
    Department of Pediatrics, Division of Paediatric Gastroenterology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Gut 60:937-43. 2011
  6. pmc Risk of diagnosed fractures in children with inflammatory bowel diseases
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 17:1125-30. 2011
  7. pmc Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
  8. doi request reprint Association of paediatric inflammatory bowel disease with other immune-mediated diseases
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, 130 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Arch Dis Child 96:1042-6. 2011
  9. doi request reprint Quality of care in inflammatory bowel disease: a review and discussion
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:125-33. 2010
  10. ncbi request reprint The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:1424-9. 2007

Collaborators

Detail Information

Publications41

  1. doi request reprint Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population-based Cohort Study With 30 Years of Follow-up Evaluation
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Electronic address
    Clin Gastroenterol Hepatol 12:265-273.e1. 2014
    ..Data regarding the risk of gastrointestinal and extraintestinal cancers in Crohn's disease (CD) and ulcerative colitis (UC) are needed to understand the clinical course of inflammatory bowel diseases (IBDs) and their treatments...
  2. pmc Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, 200 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Dig Dis Sci 58:519-25. 2013
    ..The aim of our study was to determine the prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in a commercially insured US population and compare prevalences across sociodemographic characteristics and time...
  3. pmc Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
    Michael D Kappelman
    University of North Carolina Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 17:62-8. 2011
    ..The objectives were to describe the healthcare utilization associated with IBD in an insured U.S. population and to determine how sociodemographic factors impact healthcare utilization in this population...
  4. doi request reprint Quality of care for gastrointestinal conditions: a primer for gastroenterologists
    Michael D Kappelman
    Division of Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 106:1182-7. 2011
    ....
  5. doi request reprint Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
    Michael D Kappelman
    Department of Pediatrics, Division of Paediatric Gastroenterology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Gut 60:937-43. 2011
    ..Recommendations for venous thromboembolism (VTE) prophylaxis in patients with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific risk factors...
  6. pmc Risk of diagnosed fractures in children with inflammatory bowel diseases
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 17:1125-30. 2011
    ..We sought to evaluate fracture risk in children with IBD as compared to unaffected controls and determine whether this risk is affected by geographical region (a proxy for sun/vitamin D exposure) and oral steroid use...
  7. pmc Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
    ....
  8. doi request reprint Association of paediatric inflammatory bowel disease with other immune-mediated diseases
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, 130 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Arch Dis Child 96:1042-6. 2011
    ..Associations between inflammatory bowel diseases (IBDs) and other immune-mediated diseases have been described in adult populations. Whether such associations exist in childhood-onset disease remains unknown...
  9. doi request reprint Quality of care in inflammatory bowel disease: a review and discussion
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:125-33. 2010
    ..This article reviews the history, rationale, and methods of quality measurement and improvement and identifies the unique challenges in adapting these general strategies to the care of the inflammatory bowel diseases...
  10. ncbi request reprint The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:1424-9. 2007
    ..This study sought to determine the prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in a large national sample and to compare the prevalence across geographic regions and other sociodemographic characteristics...
  11. pmc Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Gastroenterology 135:1907-13. 2008
    ....
  12. doi request reprint Nutritional concerns in pediatric inflammatory bowel disease patients
    Michael D Kappelman
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    Mol Nutr Food Res 52:867-74. 2008
    ..This article provides an overview of the epidemiology, pathophysiology, evaluation, and management of selected nutritional complications in pediatric IBD...
  13. doi request reprint Increased risk of pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 108:240-8. 2013
    ..Patients with inflammatory bowel disease (IBD) may be at increased risk for infections. We aimed to determine the pneumonia risk in IBD and how specific medications affect this risk...
  14. pmc Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases
    Lena Palmer
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2816-23. 2009
    ..In this study, we describe this exposure in a population-based sample of children with IBD and determine the characteristics associated with moderate radiation exposure...
  15. doi request reprint Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    Millie D Long
    Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Gastroenterology 143:390-399.e1. 2012
    ..Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks...
  16. doi request reprint Patient perception of chronic illness care in a large inflammatory bowel disease cohort
    Rachel L Randell
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1428-33. 2013
    ....
  17. pmc Isotretinoin use and the risk of inflammatory bowel disease: a case-control study
    Seth D Crockett
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 105:1986-93. 2010
    ..Isotretinoin is commonly prescribed for the treatment of severe acne. Although cases of inflammatory bowel disease (IBD) have been reported in isotretinoin users, a causal association remains unproven...
  18. pmc Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease
    Millie D Long
    University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:2162-8. 2011
    ....
  19. doi request reprint Validation of an Internet-Based Cohort of Inflammatory Bowel Disease (CCFA Partners)
    Rachel L Randell
    University of North Carolina School of Medicine, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease, and Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Worldwide Epidemiology GlaxoSmithKline, Research Triangle Park, North Carolina Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire and Division of Gastroenterology and Hepatology, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina
    Inflamm Bowel Dis 20:541-4. 2014
    ..We used a large Internet-based inflammatory bowel disease (IBD) cohort to validate self-reported IBD against physician reports...
  20. pmc Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Pediatrics 129:e1030-41. 2012
    ..We sought to improve chronic care delivery and outcomes for children with inflammatory bowel disease by using network-based quality improvement methods...
  21. pmc Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 8:268-74. 2010
    ..We evaluated the risk of non-melanoma skin cancer (NMSC) in patients with IBD and determined how immunosuppressive and biologic medications affect this risk...
  22. pmc Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1018-24. 2013
    ..Our aims were (1) to determine the incidence and relative risk of PCP in IBD and (2) to describe medication exposures in patients with IBD with PCP...
  23. pmc Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis
    Ashwin N Ananthakrishnan
    Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Gastroenterol Hepatol 11:965-71. 2013
    ..Sleep impairment can activate inflammatory pathways. Few prospective studies have examined the role of sleep disturbance on risk of relapse in IBD...
  24. doi request reprint Risk factors for depression in the elderly inflammatory bowel disease population
    Millie D Long
    University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, USA Center for Gastrointestinal Biology and Disease, Chapel Hill, NC, USA Electronic address
    J Crohns Colitis 8:113-9. 2014
    ..We assessed the point prevalence of depression and determined associations with disease activity, quality of life, and medication adherence in elderly patients with IBD...
  25. doi request reprint Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results
    Millie D Long
    University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 18:2099-106. 2012
    ..The widespread use of the Internet allows for unique research opportunities. We aimed to develop and follow an Internet-based cohort (e-cohort) of patients with self-reported inflammatory bowel diseases (IBD) over time...
  26. pmc Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study
    Seth D Crockett
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 18:1048-56. 2012
    ..Statin medications have antiinflammatory effects. We sought to determine whether statin use in persons with inflammatory bowel disease (IBD) was associated with reduced rates of steroid use or other markers of disease activity...
  27. pmc Nonmelanoma skin cancer in inflammatory bowel disease: a review
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1423-7. 2011
    ..We also offer recommendations for prevention of NMSC in these populations...
  28. pmc Suboptimal rates of cervical testing among women with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 7:549-53. 2009
    ..We aimed to determine cervical testing rates among women with IBD, specifically those on immunosuppressant medications, and to identify risk factors associated with low incidence of screening...
  29. pmc Burden of gastrointestinal disease in the United States: 2012 update
    Anne F Peery
    University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastroenterology 143:1179-87.e1-3. 2012
    ..Statistical analyses of the most recent data are necessary to guide GI research, education, and clinical practice. We estimate the burden of GI disease in the United States...
  30. doi request reprint Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease
    Grace J Lee
    Pediatric Gastroenterology Fellowship Program, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 55:701-6. 2012
    ..To examine sex differences in medical therapy and clinical outcomes in pediatric patients with inflammatory bowel disease (IBD)...
  31. ncbi request reprint Early life exposures as risk factors for pediatric eosinophilic esophagitis
    Elizabeth T Jensen
    Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7435, USA
    J Pediatr Gastroenterol Nutr 57:67-71. 2013
    ..The present study sought to explore early life exposures as possible risk factors for developing EoE in the pediatric population...
  32. doi request reprint Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement
    Sharmeel K Wasan
    Section of Gastroenterology, Department of Medicine, Boston Medical Center, Boston, MA and Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC
    Inflamm Bowel Dis 20:246-50. 2014
    ..Our study aimed to describe vaccine utilization by immunosuppression status, examine reasons for vaccine refusal, and identify characteristics associated with lack of influenza vaccination in patients with IBD...
  33. doi request reprint Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured
    Spencer D Dorn
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 10:278-84. 2012
    ....
  34. pmc Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:787-94. 2011
    ..We examined the association between thiazolidinedione use and ulcerative colitis (UC)-related flares...
  35. doi request reprint ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
    Wallace Crandall
    Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:450-7. 2011
    ..There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes...
  36. doi request reprint The burden of comedication among patients with inflammatory bowel disease
    Jessie P Buckley
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Neurosciences Therapy Area, GlaxoSmithKline, Research Triangle Park, North Carolina
    Inflamm Bowel Dis 19:2725-36. 2013
    ..The authors aimed to describe the prevalence and predictors of non-IBD medication use and to compare drug use among individuals with and without IBD...
  37. ncbi request reprint Intercenter variation in initial management of children with Crohn's disease
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 13:890-5. 2007
    ..We undertook this study to determine the extent of intercenter variation in the initial management of children newly diagnosed with Crohn's disease...
  38. pmc A causal association between isotretinoin and inflammatory bowel disease has yet to be established
    Seth D Crockett
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, CB 7080, Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2387-93. 2009
    ..Case reports have described a possible association between isotretinoin and inflammatory bowel disease (IBD). We critically appraised the literature on this association to assess whether it supports a causal relationship...
  39. doi request reprint Challenges in designing a national surveillance program for inflammatory bowel disease in the United States
    Millie D Long
    1Division of Gastroenterology and Hepatology, Departments of Medicine and Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 2Johns Hopkins University School of Medicine, Baltimore, Maryland 3Center for Crohn s and Colitis, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 4Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada 5Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada 6Icahn School of Medicine at Mount Sinai, New York, New York 7Epimad Registry, Epidemiology Unit, Hospital and University Lille Nord de France, Lille, France 8Kaiser Permanente Northern California, Oakland, California 9UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, California 10Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 11Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Canada 12Portland VA Medical Center, Portland, Oregon 13Alpert Medical School of Brown University, Providence, Rhode Island 14RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina 15Department of Epidemiology, Boston University School of Public Health, Boston, Harvard University
    Inflamm Bowel Dis 20:398-415. 2014
    ..This new model should focus on "surveillance of the burden of disease," including (1) natural history of disease and (2) outcomes and complications of the disease and/or treatments. ..
  40. doi request reprint Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study
    Tonya Adamiak
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Inflamm Bowel Dis 19:1218-23. 2013
    ....
  41. pmc Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population
    Lena B Palmer
    Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
    J Clin Gastroenterol 47:713-8. 2013
    ..To estimate the hepatocellular carcinoma surveillance in the Medicaid cirrhotic population...